Laura Ensign, Ph.D.

AIMBE College of Fellows Class of 2020
For outstanding contributions to nanomedicine, drug delivery, and translation of nanotechnologies from the bench to the bedside.

Controlling glaucoma: Eye drop therapy reaches posterior ocular tissues

Via Ophthalmology Times | July 22, 2022

A novel eye drop under development may provide neuroprotection to the retinal ganglion cells (RGCs). An added plus is that only once-weekly dosing is required, according to Laura Ensign, PhD, who headed up the research.

Ensign holds the Marcella E. Woll Professorship in Ophthalmology and is an associate professor of ophthalmology and vice chair for research at the Wilmer Eye Institute, Johns Hopkins Medicine in Baltimore, Maryland. This work is being conducted in collaboration with Justin Hanes, PhD, who is the Lewis J. Ort Professor of Ophthalmology and director of the Center for Nanomedicine at the Johns Hopkins University School of Medicine, and Donald Zack, MD, PhD, the Guerrieri Professor of Genetic Engineering and Molecular Ophthalmology and codirector of the Center for Stem Cells and Ocular Regenerative Medicine at the Wilmer Eye Institute.

Antiglaucoma eye drops are the mainstay of treatment for the disease, and they successfully and significantly lower the IOP. However, despite achieving a reduction of the IOP, glaucoma can continue to progress and threaten vision in many patients diagnosed with the disease. A therapy that protects the RGCs from damage was just a dream until recently. This new therapy developed by the Wilmer Eye Institute team is in the process of becoming a reality… Continue reading.


Dr. Laura Ensign Inducted into AIMBE College of Fellows

Via AIMBE | March 30, 2020

WASHINGTON, D.C. — The American Institute for Medical and Biological Engineering (AIMBE) has announced the induction of Laura Ensign, Ph.D., Marcella E. Woll Professor, Ophthalmology, Johns Hopkins University, Vice Chair for Research, Associate Professor of Ophthalmology, Chemical and Biomolecular Engineering, Biomedical Engineering, Pharmacology and Molecular Sciences, Infectious Diseases, Gynecology & Obstetrics, and Oncology, to its College of Fellows.

Election to the AIMBE College of Fellows is among the highest professional distinctions accorded to a medical and biological engineer. The College of Fellows is comprised of the top two percent of medical and biological engineers. College membership honors those who have made outstanding contributions to “engineering and medicine research, practice, or education” and to “the pioneering of new and developing fields of technology, making major advancements in traditional fields of medical and biological engineering, or developing/implementing innovative approaches to bioengineering education.”

Dr. Ensign was nominated, reviewed, and elected by peers and members of the College of Fellows for “outstanding contributions to nanomedicine, drug delivery, and translation of nanotechnologies from the bench to the bedside.